A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. - Bivens E; Atiq O; Evans T; Bimali M; Brown G; Crane J; Darwish N; Faulkner JL; Govindarajan R; Johnson A; Kurilung A; Lazarenko O; et al. (Oncotarget, 2026)